IMPLANT SCIENCES CORP
IMX
IMX was delisted on the 3rd of April, 2009.
0 hedge funds and large institutions have $0 invested in IMPLANT SCIENCES CORP in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $116K → $0 (-$116K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$116K |
IMX Hedge Fund Activity: Q3 2013 in Review
0 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in IMPLANT SCIENCES CORP (IMX) for Q3 2013, worth a combined $0 — down 100% from $116K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IMX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was North Star Investment Management, exiting entirely with an estimated $116K sold.
- 0 institutional investors held IMPLANT SCIENCES CORP (IMX) as of Q3 2013, down from 1 in Q2 2013.
- Funds reported $0 of IMPLANT SCIENCES CORP stock for Q3 2013, down 100% quarter-over-quarter.
- 0 funds opened new IMPLANT SCIENCES CORP positions in Q3 2013 and 1 closed out, a net change of -1 holder.
- The largest IMPLANT SCIENCES CORP seller in Q3 2013 was North Star Investment Management, an estimated $116K sold.
Based on aggregated 13F filings for Q3 2013.